• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

ovarian cancer

ovarian cancer cancer awareness
Pharma

Keytruda delivers trial win in some patients with ovarian cancer

Merck's cancer superstar Keytruda has not yet been able to add an ovarian cancer-specific nod to its impressive lineup of approved indications.
Zoey Becker May 15, 2025 10:56am
Go sign green light

FDA approves Verastem's combo for rare form of ovarian cancer

May 9, 2025 10:42am
dart board miss failure

GSK trial result mirrors Merck's problem in ovarian cancer

Dec 20, 2024 10:46am
Keytruda

Keytruda-Lynparza combo scores tepid win in ovarian cancer trial

Dec 9, 2024 11:18am
Johnson  Johnson talc

In 3rd bankruptcy bid, J&J sweetens talc settlement offer to $8B

Sep 23, 2024 9:33am
talc

Oregon judge sides with J&J, overturning $260M talc verdict

Sep 17, 2024 8:17am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings